ストックスクリーナーアプリを入手
303.44
0.32%
0.98
アフターアワーズ：
303.44
前日終値:
$302.46
開ける：
$301.52
24時間の取引高:
727.34K
Relative Volume:
0.42
時価総額：
$59.04B
収益：
$328.68B
当期純損益:
$2.55B
株価収益率:
23.28
EPS:
13.0349
ネットキャッシュフロー:
$1.56B
1週間 パフォーマンス:
+2.34%
1か月 パフォーマンス:
+7.89%
6か月 パフォーマンス:
-9.61%
1年 パフォーマンス:
+2.06%
1日の値動き範囲:
$300.76
$304.79
1週間の範囲:
$292.50
$310.45
52週間の値動き範囲:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Compare COR vs MCK, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
303.44 | 59.04B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
805.96 | 94.36B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
235.80 | 55.23B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.40 | 9.61B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.52 | 1.30B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | アップグレード | Jefferies | Hold → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-09-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2023-01-31 | 再開されました | Evercore ISI | Outperform |
| 2022-10-11 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-07-11 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-05-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-04-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | 再開されました | Evercore ISI | In-line |
| 2021-02-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-02-02 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-01-06 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-01-06 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 開始されました | Mizuho | Neutral |
| 2020-08-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 開始されました | Barclays | Underweight |
| 2020-06-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 再開されました | Credit Suisse | Outperform |
| 2020-04-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-03-17 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-11 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-07-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 開始されました | Guggenheim | Buy |
| 2019-04-10 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-02-11 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2018-10-26 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 開始されました | Berenberg | Buy |
| 2018-07-17 | 再開されました | Stifel | Hold |
| 2018-04-09 | 開始されました | MoffettNathanson | Buy |
| 2018-03-12 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 開始されました | JP Morgan | Neutral |
| 2017-09-22 | 開始されました | William Blair | Outperform |
すべてを表示
Cencora Inc (COR) 最新ニュース
ETFs Investing in Cencora, Inc. Stocks - TradingView
Deals tracker: IKS Health acquires TruBridge in $557M deal - Modern Healthcare
Cencora stock trades steadily as healthcare distribution scale supports long-term growth - ad-hoc-news.de
Cencora Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Pricing Headwinds and Industry Trends Cut Into Cencora's 2026 Sales, but Fundamentals Remain Strong - Morningstar
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Centene Corp navigates Medicaid shifts. Investors track managed care margins - Ad-hoc-news.de
Cencora Inc. focuses on pharmaceutical distribution scale as investors eye healthcare demand - ad-hoc-news.de
AQR Managed Futures Strategy Fund's Cencora Inc(COR) Holding History - GuruFocus
Form 4 Cencora Inc For: 7 July By Investing.com - Investing.com Nigeria
Cencora (COR) EVP adds common stock through employee purchase plan - Stock Titan
Cencora (COR) EVP acquires stock through Employee Stock Purchase Plan - Stock Titan
Cencora Inc. focuses on distribution strength as investors weigh long-term growth - ad-hoc-news.de
Centene Corp evaluates its strategy as US health coverage needs evolve - AD HOC NEWS
Cencora Inc. highlights its role in pharmaceutical distribution. Investors watch the company’s evo - AD HOC NEWS
Steve Collis: Pharmaceutical Distribution Leader and Former Chairman, President, and CEO of Cencora - BBN Times
Enterprise value to revenue forward of Cencora, Inc. – NYSE:COR - TradingView
3 Defensive Stocks Investors Are Watching As Markets Turn Cautious - Sahm
Cencora (COR) Could Be 15% Undervalued As Earnings Date Nears - simplywall.st
Cencora announces Q3 FY26 earnings release date - scanx.trade
Press Release: Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release - Moomoo
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release - marketscreener.com
Cencora Inc. focuses on pharmaceutical distribution and healthcare services - AD HOC NEWS
Cencora CubixxCT from Cencora Inc.cold-chain automation for hospital pharmacies - AD HOC NEWS
Form 4 Cencora Inc For: 30 June By Investing.com - Investing.com Canada
Cencora (COR) CFO receives 21,304 restricted stock units vesting through 2029 - Stock Titan
Cencora (COR) CFO files Form 3 showing small direct and trust holdings - Stock Titan
Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase - marketscreener.com
Cencora reports steady business model, shares anchored in US healthcare distribution - AD HOC NEWS
Cencora, Inc. (COR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
The Velocity patient support solution from Cencora Inc.integrated care for specialty therapies - AD HOC NEWS
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora operations and strategy, shares reflect ongoing integration of COR acquisition - AD HOC NEWS
Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap - Yahoo Finance
Nucleus inventory solution from Cencora Inc.modular cabinets and tighter control for specialty pr - AD HOC NEWS
Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO - Yahoo Finance
Cencora revises 2026 outlook, shares underpinned by buyback and analyst support - Ad-hoc-news.de
Knights of Columbus Large Cap Value Fund's Cencora Inc(COR) Holding History - GuruFocus
Cencora, S&P 500 peer under pressure, shares lag broader healthcare distributors - Ad-hoc-news.de
3 Big Reasons to Love Cencora (COR) - Yahoo Finance
Cencora (COR) Stock After Healthcare Supply Chain Reassessment Is The Market Overreacting - simplywall.st
Price to sales forward of Cencora, Inc. – NYSE:COR - TradingView
Cencora adjusts amid healthcare shifts, shares trade steadily on NYSE - Ad-hoc-news.de
Enterprise value to revenue forward of Cencora, Inc. – LS:766149 - TradingView
Enterprise value to EBIT forward of Cencora, Inc. – NYSE:COR - TradingView
Cencora, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh - TradingView
AQR Trend Total Return Fund's Cencora Inc(COR) Holding History - GuruFocus
Cencora, Inc. Actuals & Estimates (NYSE:COR) - TradingView
Enterprise value to EBIT forward of Cencora, Inc. – LS:766149 - TradingView
COR Forecast — Price Target — Prediction for 2027 - TradingView
Cencora analyst targets imply upside, shares in S&P 500 healthcare focus - Ad-hoc-news.de
Cencora Inc (COR) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
大文字化:
|
ボリューム (24 時間):